Minimally-Invasive Rapid Blood Test
State of Development
This Minimally-Invasive Glucose Blood Test is currently approved by the FDA.

Product Info
Rapid Blood Analyzer (RBA)

Our rapid point of care blood analyzer, the Rapid Blood Analyzer (RBA), uses a single drop of blood to present comprehensive results in less than three seconds. These results can include hemoglobin, glucose, cholesterol, different proteins, and so forth. Kaligia Biosciences’s self-calibrating technique to acquire accurate and repeatable results sets it apart from others who have tried it in the past.
Hospitals and clinics spend heavily on monitoring, recording and managing blood diagnostics. The process is slow, error prone and resource intensive which creates numerous issues for patients and clinicians both.
Our technology expects to effectively increase patient proactiveness and compliance by making a tedious and painful process faster, cheaper and convenient for a range of target healthcare providers.